Refacto AI

Industry story

OpenAI's Astra model raises AI safety fears over 'neuralese' reasoning

evals interpretability security

A report from The Information revealed that OpenAI's new Astra model uses a technique called 'recurrent depth' (also called a 'looped transformer'), which allows the model to do more reasoning internally rather than writing out step-by-step 'chain of thought' notes that researchers can monitor. Chain of thought — where a model writes intermediate reasoning steps in readable text — has been a key safety tool, letting developers catch deceptive or misaligned behavior. Moving toward opaque internal reasoning, dubbed 'neuralese,' would make it far harder to monitor AI for bad behavior, prompting prominent safety researcher Ryan Greenblatt to call it potentially 'the single worst development for AI security/safety to date.'

OpenAI chief scientist Jakub Pachocki pushed back, arguing that Astra's computation depth is 'within a factor of two of GPT-4,' suggesting the model still externalizes much of its reasoning. However, critics including Apollo Research's Marius Hobbhahn warned of a slippery slope: each incremental increase in recurrent depth boosts performance, creating competitive pressure to keep dialing it up at the expense of monitorability. OpenAI employees and others called for a multi-company commitment to preserving chain-of-thought monitoring, while some argued the episode highlights the need for mandated independent audits, since there is currently no reliable way for outsiders to verify whether a model's reasoning architecture is safe.

Analysis

Showing the shorter version.

OpenAI shipped a model called Astra that does more of its reasoning inside its own weights instead of writing out the step-by-step chain-of-thought (CoT) tokens that safety researchers and enterprise compliance teams have been reading. The technique is a looped transformer: run the same block of math repeatedly to get deeper reasoning without adding parameters. Safety researcher Ryan Greenblatt called it possibly "the single worst development for AI security/safety to date." The term floating around for reasoning that never surfaces as readable text is "neuralese."

What's actually at stake

CoT was never proven to prevent bad behavior. Models post-hoc rationalize; the written reasoning can be flatly wrong about what the weights actually did. OpenAI president of research Jakub Pachocki's rebuttal is worth taking seriously: Astra's compute depth is "within a factor of two of GPT-4," which already did enormous internal computation nobody reads. So the Greenblatt five-alarm reading may be overblown.

But here's where the safety concern earns its place. The field ran on an unspoken bet that competitive pressure wouldn't break monitorability before alignment research caught up. Even a weak monitoring tool matters when you have no replacement. Marius Hobbhahn of Apollo Research names the mechanism clearly: each depth increment is a free performance gain, so no single lab caps it voluntarily, and the whole thing ratchets. The multi-company pledge to preserve CoT is unverifiable without mandatory architectural disclosure, which no government requires.

The practical problem for builders and buyers

If your production pipeline scrapes CoT tokens as structured intermediate data, for human-review queues, for logging, for quality signals, a model that stops externalizing reasoning breaks those integrations quietly. Day one looks fine because benchmark accuracy holds. Ninety days in, your trust-and-safety team can't explain a decision to enterprise legal.

For CTOs in healthcare or finance, this is a contract problem. Explainability clauses, audit logs, and indemnification language all get weaker on a looped architecture. The vendors won't offer a monitorable mode unprompted. Put it on the table at renewal now.

The call

By September 2027, at least one other frontier lab among Anthropic, Google DeepMind, xAI, or Meta will have shipped a production model using recurrent-depth or equivalent looped-reasoning that reduces externalized CoT, and no binding multi-company agreement to preserve CoT monitoring will be in force. Confidence: medium.

The cost and benchmark math both point the same way. A binding cross-lab commitment would require competitors to leave performance and cost savings on the table with no enforcement mechanism, which has no precedent in this industry. The one thing that delays it is the technique proving harder to stabilize in training than Astra's release suggests.

Watch Pachocki's "factor of two" number across the next model cycle. If it holds, this is a warning shot. If it quietly climbs, the leaderboard wins and every lab follows.

Also covered this issue

Comments